Suppr超能文献

Introduction: landscape of opioid dependence.

作者信息

Jan Saira A

机构信息

Horizon Blue Cross Blue Shield of New Jersey, Newark, NJ 07105-2200, USA.

出版信息

J Manag Care Pharm. 2010 Feb;16(1 Suppl B):S4-8. doi: 10.18553/jmcp.2010.16.S1-B.4.

Abstract

BACKGROUND

The use of opioids for chronic noncancer pain increased 222% from 1992 to 2002. Opioid dependence has also increased significantly, leading to a burden on patients, employers, insurers, society, and the entire health care system. It is imperative that opioid dependence is addressed and treated properly, in order to return patients to being productive participants in the workplace and society.

OBJECTIVE

To provide an overview of addiction, abuse, and dependence and identify risk factors for addiction.

SUMMARY

Studies have shown that intensive use of opioids is associated with increased utilization of costly health care services, prolonged disability, and continued use of opioids, leading to abuse and dependence in many patients. While identifying patients at risk for developing opioid dependence is difficult, there are many risk stratification tools now available to practitioners, including the Opioid Risk Tool (ORT) or Screener and Opioid Assessment for Patients with Pain (SOAPP). Understanding the differences between dependence, addiction, and tolerance is essential to managing patients on opioids.

CONCLUSION

It is imperative that patients be properly managed when being treated for pain. Physicians and employers have to be able to identify patients at risk for opioid abuse or exhibiting symptoms of opioid abuse and know how to address their needs.

摘要

相似文献

1
Introduction: landscape of opioid dependence.
J Manag Care Pharm. 2010 Feb;16(1 Suppl B):S4-8. doi: 10.18553/jmcp.2010.16.S1-B.4.
2
Empirical view of opioid dependence.
J Manag Care Pharm. 2010 Feb;16(1 Suppl B):S9-13. doi: 10.18553/jmcp.2010.16.S1-B.9.
3
Patient perspective, complexities, and challenges in managed care.
J Manag Care Pharm. 2010 Feb;16(1 Suppl B):S22-5. doi: 10.18553/jmcp.2010.16.S1-B.22.
4
Chronic opioid therapy issues associated with opioid abuse potential.
J Opioid Manag. 2009 Sep-Oct;5(5):287-300. doi: 10.5055/jom.2009.0029.
7
Opioid therapy in patients with chronic noncancer pain: diagnostic and clinical challenges.
Adv Psychosom Med. 2011;30:61-91. doi: 10.1159/000324067. Epub 2011 Apr 19.
8
Continuous opioid treatment for chronic noncancer pain: a time for moderation in prescribing.
Postgrad Med. 2009 Jul;121(4):61-6. doi: 10.3810/pgm.2009.07.2032.

引用本文的文献

3
Pharmacological Profiles of Oligomerized μ-Opioid Receptors.
Cells. 2013 Oct 11;2(4):689-714. doi: 10.3390/cells2040689.
4
Improving public health through access to and utilization of medication assisted treatment.
Int J Environ Res Public Health. 2011 Oct;8(10):4102-17. doi: 10.3390/ijerph8104102. Epub 2011 Oct 24.
5
Elevated pain sensitivity in chronic pain patients at risk for opioid misuse.
J Pain. 2011 Sep;12(9):953-63. doi: 10.1016/j.jpain.2011.02.357. Epub 2011 Jun 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验